| Target Price | $10.20 |
| Price | $4.12 |
| Potential |
147.57%
register free of charge
|
| Number of Estimates | 9 |
|
9 Analysts have issued a price target Tvardi Therapeutics 2026 .
The average Tvardi Therapeutics target price is $10.20.
This is
147.57%
register free of charge
$54.60
1,225.24%
register free of charge
$4.04
1.94%
register free of charge
|
|
| A rating was issued by 14 analysts: 8 Analysts recommend Tvardi Therapeutics to buy, 6 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Tvardi Therapeutics stock has an average upside potential 2026 of
147.57%
register free of charge
|
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Raymond James |
Locked
➜
Locked
|
Locked | Oct 14 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Oct 13 2025 |
| BTIG |
Locked
➜
Locked
|
Locked | Oct 13 2025 |
| Raymond James |
Locked
➜
Locked
|
Locked | Jul 14 2025 |
| Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Jul 11 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Jun 12 2025 |
| Oppenheimer |
Locked
➜
Locked
|
Locked | May 21 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Raymond James:
Locked
➜
Locked
|
Oct 14 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Oct 13 2025 |
|
Locked
BTIG:
Locked
➜
Locked
|
Oct 13 2025 |
|
Locked
Raymond James:
Locked
➜
Locked
|
Jul 14 2025 |
|
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Jul 11 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Jun 12 2025 |
|
Locked
Oppenheimer:
Locked
➜
Locked
|
May 21 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


